77 related articles for article (PubMed ID: 3687458)
21. Are receptor studies useful for clinical practice?
Richelson E
J Clin Psychiatry; 1983 Sep; 44(9 Pt 2):4-9. PubMed ID: 6313632
[TBL] [Abstract][Full Text] [Related]
22. The effect of GYKI-32 887 on dopamine (D2) and serotonin (5-HT1 and 5-HT2) receptors.
Berzétei IP; Bagdy E; Hardy M; Borsy J
Pol J Pharmacol Pharm; 1985; 37(3):237-42. PubMed ID: 4070077
[TBL] [Abstract][Full Text] [Related]
23. [3H]-quinelorane binds to D2 and D3 dopamine receptors in the rat brain.
Gackenheimer SL; Schaus JM; Gehlert DR
J Pharmacol Exp Ther; 1995 Sep; 274(3):1558-65. PubMed ID: 7562534
[TBL] [Abstract][Full Text] [Related]
24. The interaction of lisuride, an ergot derivative, with serotonergic and dopaminergic receptors in rabbit brain.
Rosenfeld MR; Makman MH
J Pharmacol Exp Ther; 1981 Mar; 216(3):526-31. PubMed ID: 7205633
[TBL] [Abstract][Full Text] [Related]
25. [Change in dopamine and serotonin receptor sensitivity following chronic chlorpromazine administration].
Zharkovskiĭ AM; Riago LK; Arro AG
Zh Vyssh Nerv Deiat Im I P Pavlova; 1980; 30(1):165-8. PubMed ID: 7189932
[TBL] [Abstract][Full Text] [Related]
26. The pharmacology of antidepressants at the synapse: focus on newer compounds.
Richelson E
J Clin Psychiatry; 1994 Sep; 55 Suppl A():34-9; discussion 40-1, 98-100. PubMed ID: 7961541
[TBL] [Abstract][Full Text] [Related]
27. Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding.
Kilpatrick GJ; Jones BJ; Tyers MB
Nature; 1987 Dec 24-31; 330(6150):746-8. PubMed ID: 3696238
[TBL] [Abstract][Full Text] [Related]
28. [Relevance of the sedative-tranquilizing effect of l-tetrahydropalmatine to brain monoaminergic neurotransmitters].
Jin GZ; Xu J; Zhang FT; Yu LP; Li JH; Wang XL
Zhongguo Yao Li Xue Bao; 1983 Mar; 4(1):4-10. PubMed ID: 6135292
[No Abstract] [Full Text] [Related]
29. Studies on the action of (+/-)sulpiride on dopamine receptors in the rat brain in vivo.
Hasan F; Leonard BE
Neuropharmacology; 1981 Dec; 20(12B):1327-30. PubMed ID: 7198724
[No Abstract] [Full Text] [Related]
30. [Influence of the selective ligands of dopamine and 5-hydroxytryptamine receptors on the tolerance to global cerebral ischemia].
Kulinskiĭ VI; Gavrilov SS
Eksp Klin Farmakol; 2006; 69(6):20-3. PubMed ID: 17209458
[TBL] [Abstract][Full Text] [Related]
31. Lasting changes in high affinity 3H-spiperone binding to the rat striatum and mesolimbic area after chronic methamphetamine administration: evaluation of dopaminergic and serotonergic receptor components.
Akiyama K; Sato M; Kashihara K; Otsuki S
Biol Psychiatry; 1982 Dec; 17(12):1389-402. PubMed ID: 7159638
[TBL] [Abstract][Full Text] [Related]
32. Aporphines. 30. (-)-N(2-chloroethyl)-10,11-dihydroxynor-aporphine (chloroethylnorapomorphine), a novel irreversible dopamine receptor antagonist.
Neumeyer JL; Law SJ; Baldessarini RJ; Kula NS
J Med Chem; 1980 Jun; 23(6):594-5. PubMed ID: 7392026
[No Abstract] [Full Text] [Related]
33. Neurotoxicity of endosulfan in young and adult rats.
Seth PK; Saidi NF; Agrawal AK; Anand M
Neurotoxicology; 1986; 7(2):623-35. PubMed ID: 3024081
[No Abstract] [Full Text] [Related]
34. Dopamine agonists: structure-activity relationships.
Cannon JG
Prog Drug Res; 1985; 29():303-414. PubMed ID: 3911262
[No Abstract] [Full Text] [Related]
35. Effects of aporphine and emetine alkaloids on central dopaminergic mechanisms in rats.
Lal S; Sourkes TL; Missala K; Belendiuk G
Eur J Pharmacol; 1972 Oct; 20(1):71-9. PubMed ID: 4674034
[No Abstract] [Full Text] [Related]
36. Lack of effect of chronic aspartame ingestion on aminergic receptors in rat brain.
Reilly MA; Debler EA; Fleischer A; Lajtha A
Biochem Pharmacol; 1989 Dec; 38(23):4339-41. PubMed ID: 2597204
[No Abstract] [Full Text] [Related]
37. Dopamine autoreceptors differ pharmacologically from postsynaptic dopamine receptors: effects of (-)-N-(2-chloroethyl)-norapomorphine.
Lehmann J; Langer SZ
Eur J Pharmacol; 1982 Jan; 77(1):85-6. PubMed ID: 7060630
[No Abstract] [Full Text] [Related]
38. Influence of a chronic new potential antidepressant, 1-[3-(dimethylamino)propyl]-5-methyl-3-phenyl-1H-indazole(FS32) and its N-desmethylated compound(FS97): treatment on monoaminergic receptor sensitivity in the rat brain.
Koide T; Matsushita H
Neuropharmacology; 1981 Mar; 20(3):285-92. PubMed ID: 7266786
[No Abstract] [Full Text] [Related]
39. Comparison of the dopaminergic effects of N-substituted aporphines.
Menon MK; Clark WG; Cannon JG
J Pharm Pharmacol; 1976 Oct; 28(10):778-81. PubMed ID: 10377
[No Abstract] [Full Text] [Related]
40. [Pharmacological basis of phlebology].
Sicuteri F; Giotti A
Rev Clin Esp; 1979 Sep; 154(6):271-2. PubMed ID: 231285
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
